Reckitt (GB:RKT)
LSE:RKT
Top Page
Reckitt
(LSE:RKT)
Select Model
Select Model
Rating:66Neutral
Price Target:
6,026.00 p
▲(16.15% Upside)
Action:DowngradedDate:03/07/26
The score is driven primarily by improved financial performance (notably profitability and lower leverage) and supportive valuation (moderate P/E and solid yield). These are tempered by weak technicals (below key moving averages with negative momentum) and earnings-call-flagged near-term pressures on cash flow, leverage, and 2026 margin/EPS visibility.
Positive Factors
Brand portfolio & innovation
Reckitt's concentrated portfolio of 11 'power brands' and a steady stream of launches (Durex Intensity, Lysol/Dettol innovations, Mucinex FDA NDA) support durable brand equity, repeat purchases and pricing power across channels. This underpins resilient revenue and scalable marketing returns over the medium term.
Negative Factors
Weaker cash conversion
Despite higher reported earnings, operating cash flow fell and FCF conversion dipped, indicating working-capital or timing pressures. Persistently weaker cash conversion would constrain financing of capex, M&A or buybacks, and make the company more sensitive to margin or revenue shocks over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Brand portfolio & innovation
Reckitt's concentrated portfolio of 11 'power brands' and a steady stream of launches (Durex Intensity, Lysol/Dettol innovations, Mucinex FDA NDA) support durable brand equity, repeat purchases and pricing power across channels. This underpins resilient revenue and scalable marketing returns over the medium term.
Read all positive factors
Reckitt (RKT) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£33.39B
Dividend Yield3.44%
Average Volume (3M)1.55M
Price to Earnings (P/E)12.3
Beta (1Y)0.90
Revenue Growth-2.41%
EPS Growth-16.41%
CountryUK
Employees37,900
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)1.84
Shares Outstanding643,523,600
10 Day Avg. Volume1,239,780
30 Day Avg. Volume1,554,548
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)5.05
Price to Sales (P/S)2.76
P/FCF Ratio22.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£6,335.30Price Target Upside22.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)3.43
Revenue Forecast (FY)£12.78B
Reckitt Business Overview & Revenue Model
Company Description
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; di...
How the Company Makes Money
Reckitt generates revenue primarily through the sale of its branded consumer products in the health, hygiene, and nutrition sectors. The company's revenue model is based on a mix of direct-to-consumer sales, retail partnerships, and e-commerce pla...
Reckitt Earnings Call Summary
Earnings Call Date:Mar 05, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Jul 29, 2026
Earnings Call Sentiment Positive
The call presents a predominantly positive operational picture driven by strong Emerging Markets growth, margin expansion, tangible returns to shareholders, successful innovation and early results from supply chain investments. However, meaningful near-term headwinds remain: a weak Europe and soft seasonal OTC, modest EPS growth (partly due to tax and FX), one-off impacts and stranded costs from the Essential Home divestment, and a temporary rise in leverage and fixed-cost pressure in 2026. Management is confident the Fuel for Growth program and continued investment will offset many of these pressures over time and deliver medium-term targets.Positive Updates
Core and Group Revenue Growth
Core Reckitt like-for-like net revenue grew 5.2% in 2025 (volume +1.5%, price/mix +3.7%); group net revenue increased 5.0%. Excluding seasonal OTC, Core Reckitt grew 7.0% year-on-year.
Negative Updates
Weakness in Europe
Europe net revenue declined 1.4% for the year with volumes down 3.1%; category growth slowed to broadly flat and promotional intensity increased, weighing on growth and shares in the region.
Read all updates
Q4-2025 Updates
Positive
Negative
Core and Group Revenue Growth
Core Reckitt like-for-like net revenue grew 5.2% in 2025 (volume +1.5%, price/mix +3.7%); group net revenue increased 5.0%. Excluding seasonal OTC, Core Reckitt grew 7.0% year-on-year.
Read all positive updates
Company Guidance
Reckitt guided Core Reckitt like‑for‑like net revenue growth of 4–5% for 2026 (reiterating its medium‑term target) with Q1 expected below the full‑year pace; Mead Johnson Nutrition is expected to grow low single digits LFL in 2026 but to see a mid‑single‑digit revenue decline in Q1 (lapping a 2025 retailer inventory build). Group adjusted operating profit should largely offset stranded costs from the Essential Home divestment via the Fuel for Growth program (group adjusted operating profit margin exited 2025 at 24.9%); the Fuel for Growth envelope remains c. GBP1bn and Reckitt now expects to exit 2027 with a fixed cost base below 19% (group fixed costs were 19.4% in 2025). CapEx guidance for 2026 is around 4% of revenue (2025 CapEx was GBP592m); free cash flow was GBP1.7bn in 2025 (71% conversion) and is expected to be similar in 2026–27 while restructuring runs, then normalise after end‑2027; net debt/EBITDA closed 2025 at 1.6x (c.2x after the GBP1.6bn special dividend) and is expected to rise toward ~2.5x by H1 2026 before trending down. Capital return remains active (FY dividend proposed +5%, 2025 returns totaled GBP2.3bn including GBP900m buybacks and a GBP1.6bn special dividend); EPS will receive Vestacy‑related income (USD300m vendor loan note, 30% associate stake and ~GBP25m pretax services) and benefit from share consolidation/buybacks but faces a 2026 dilution headwind from the Essential Home divestment; tax guidance is around 27% and c.55% of FX/commodity exposures are hedged over a 12‑month horizon.Reckitt Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
63
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 14.21B | 14.17B | 14.61B | 14.45B | 13.23B |
| Gross Profit | 8.63B | 8.60B | 8.76B | 8.36B | 7.69B |
| EBITDA | 4.22B | 2.95B | 3.19B | 3.90B | 465.00M |
| Net Income | 3.18B | 1.43B | 1.64B | 2.33B | -32.00M |
Balance Sheet | |||||
| Total Assets | 25.07B | 25.30B | 27.14B | 28.74B | 26.95B |
| Cash, Cash Equivalents and Short-Term Investments | 1.95B | 760.00M | 1.39B | 1.16B | 1.26B |
| Total Debt | 8.43B | 8.66B | 8.54B | 8.88B | 9.56B |
| Total Liabilities | 17.29B | 18.58B | 18.67B | 19.26B | 19.49B |
| Stockholders Equity | 7.75B | 6.70B | 8.45B | 9.44B | 7.40B |
Cash Flow | |||||
| Free Cash Flow | 1.76B | 2.22B | 2.19B | 1.95B | 1.32B |
| Operating Cash Flow | 2.30B | 2.68B | 2.64B | 2.40B | 1.70B |
| Investing Cash Flow | 1.20B | -396.00M | -466.00M | -139.00M | 239.00M |
| Financing Cash Flow | -2.43B | -2.71B | -1.81B | -2.38B | -2.29B |
Reckitt Technical Analysis
Negative
5188.00
Price Trends
5856.81
Negative
5925.85
Negative
5715.69
Negative
Market Momentum
-223.62
Negative
34.99
Neutral
68.20
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:RKT, the sentiment is Negative. The current price of 5188 is below the 20-day moving average (MA) of 5258.20, below the 50-day MA of 5856.81, and below the 200-day MA of 5715.69, indicating a bearish trend. The MACD of -223.62 indicates Negative momentum. The RSI at 34.99 is Neutral, neither overbought nor oversold. The STOCH value of 68.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:RKT.
Reckitt Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £15.58B | 17.33 | 28.56% | 1.96% | 6.00% | 42.42% | |
74 Outperform | £23.95B | 5.16 | 42.31% | 5.57% | 2.69% | -16.50% | |
71 Outperform | £91.18B | 11.79 | 28.78% | 3.85% | -2.98% | -16.90% | |
70 Outperform | £95.48B | 11.87 | 6.03% | 5.67% | -2.24% | ― | |
69 Neutral | £13.30B | 15.47 | 9.22% | 2.98% | -3.06% | -26.93% | |
66 Neutral | £33.39B | 12.30 | 38.45% | 3.44% | -2.41% | -16.41% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
* Consumer Defensive Sector Average
GB:RKT
Reckitt
5,188.00
626.24
13.73%
GB:ABF
Associated British Foods
1,890.50
66.10
3.62%
GB:BATS
British American Tobacco
4,407.00
1,538.10
53.61%
GB:CCH
Coca Cola HBC
4,274.00
1,025.18
31.56%
GB:IMB
Imperial Brands
3,077.00
468.97
17.98%
GB:ULVR
Unilever
4,172.50
-637.65
-13.26%
Reckitt Corporate Events
Business Operations and StrategyExecutive/Board Changes
Reckitt refreshes board with senior hires from Novartis and Smith+Nephew
Positive
Mar 5, 2026
Reckitt Benckiser has announced changes to its board, appointing Novartis CFO Harry Kirsch and Smith+Nephew CEO Deepak Nath as non-executive directors effective 1 April 2026, with Kirsch also set to join the audit committee from May. Both bring ex...
Business Operations and StrategyDividendsFinancial DisclosuresRegulatory Filings and Compliance
Reckitt posts 2025 results and lifts dividend by 5%
Positive
Mar 5, 2026
Reckitt Benckiser has published its full-year results for 2025 and confirmed that the complete statement is available on its website and through the UK financial regulator’s storage mechanism. The disclosure underlines the company’s co...
Regulatory Filings and Compliance
Reckitt Updates Total Voting Rights to 644.96 Million Shares
Neutral
Mar 2, 2026
Reckitt Benckiser Group plc has confirmed its current capital structure under U.K. disclosure rules, stating that as of 27 February 2026 it has 674,005,752 issued ordinary shares, of which 29,043,683 are held in treasury without voting rights. Thi...
Regulatory Filings and Compliance
Reckitt CEO and CFO Boost Holdings Through Dividend Reinvestment Plan
Positive
Feb 23, 2026
Reckitt disclosed that chief executive Kris Licht acquired 2,109 ordinary shares through the company’s Dividend Reinvestment Plan on 20 February, at a price of £64.61933 per share, in a transaction on the London Stock Exchange. Chief fi...
Business Operations and Strategy
Reckitt Leaders to Address CAGNY Without New Financial Disclosures
Neutral
Feb 19, 2026
Reckitt said its chief executive, Kris Licht, and chief financial officer, Shannon Eisenhardt, will address the Consumer Analyst Group of New York Conference in Orlando, underscoring the company’s efforts to engage closely with the investmen...
Delistings and Listing ChangesRegulatory Filings and ComplianceStock Split
Reckitt Share Consolidation Takes Effect as New Voting Capital Confirmed
Neutral
Feb 2, 2026
Reckitt Benckiser Group has made effective a previously approved share consolidation linked to its special dividend, with the company’s new ordinary shares admitted today to the FCA’s Official List and to trading on the London Stock Ex...
Business Operations and StrategyStock Buyback
Reckitt Completes Second Tranche of £1 Billion Share Buyback Programme
Positive
Feb 2, 2026
Reckitt Benckiser Group plc has completed the second tranche of its previously announced £1 billion share buyback programme, purchasing 3,461,470 ordinary shares between 22 October 2025 and 28 January 2026 at an average price of £59.46, ...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 58,785 Shares, Sets New Voting Rights Total
Neutral
Jan 29, 2026
Reckitt Benckiser Group plc has repurchased 58,785 of its ordinary shares from BNP Paribas SA under its shareholder-approved buyback authority, paying a volume-weighted average price of 5,953.57 pence per share, with the shares to be held in treas...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 58,860 Shares, Updates Voting Rights Count
Neutral
Jan 28, 2026
Reckitt Benckiser Group plc has repurchased 58,860 of its ordinary shares from BNP Paribas SA under an existing shareholder-authorised buyback programme, paying a volume-weighted average price of 5,945.65 pence per share, with the shares to be hel...
Business Operations and StrategyStock BuybackDividendsShareholder MeetingsStock Split
Reckitt Shareholders Approve Special Dividend, Share Consolidation and Capital Authorities
Positive
Jan 27, 2026
Shareholders of Reckitt Benckiser Group plc have overwhelmingly approved all resolutions at a general meeting held on 27 January 2026, including the declaration of a special dividend of 235 pence per existing ordinary share and a share consolidati...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 51,050 Shares, Updates Voting Rights Total
Neutral
Jan 27, 2026
Reckitt Benckiser Group plc has repurchased 51,050 of its ordinary shares from BNP Paribas SA under an existing shareholder authority, with the shares to be held in treasury. Following this transaction, Reckitt now holds 30,355,264 shares in treas...
Business Operations and StrategyRegulatory Filings and Compliance
Reckitt Denies Reported Product Recall in the Philippines
Positive
Jan 26, 2026
Reckitt Benckiser Group has refuted a media report suggesting it had been subject to a product recall in the Philippines, stating that the Mead Johnson Nutrition product cited, Enfamil ProSobee Simply Plant-Based Infant Formula, is neither registe...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,670 Shares, Updates Voting Rights Total
Neutral
Jan 26, 2026
Reckitt Benckiser Group plc has repurchased 49,670 of its ordinary shares from BNP Paribas SA under its existing shareholder authority, with the shares to be held in treasury rather than cancelled. Following this transaction, Reckitt now holds 30,...
Stock BuybackRegulatory Filings and Compliance
Reckitt Repurchases 49,250 Shares, Updates Total Voting Rights
Neutral
Jan 23, 2026
Reckitt Benckiser Group plc has repurchased 49,250 of its ordinary shares from BNP Paribas SA under an existing shareholder-authorised buyback programme, with the shares to be held in treasury. Following this transaction, Reckitt now holds 30,368,...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,430 Shares, Sets New Voting Rights Total
Positive
Jan 22, 2026
Reckitt Benckiser Group has repurchased 49,430 of its ordinary shares from BNP Paribas as part of its ongoing share buyback programme authorised by shareholders at its 2025 AGM, with the shares to be held in treasury. Following this transaction, R...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,270 Shares, Sets New Voting Rights Total
Neutral
Jan 21, 2026
Reckitt Benckiser Group plc has repurchased 49,270 of its ordinary shares from BNP Paribas SA under its existing shareholder authority, at a volume-weighted average price of 6,088.22 pence per share, with the shares to be held in treasury. Followi...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,100 Shares, Updates Voting Rights Total
Neutral
Jan 20, 2026
Reckitt Benckiser Group plc has repurchased 49,100 of its 10 pence ordinary shares from BNP Paribas SA, under an existing shareholder authority granted at its May 2025 AGM, with the shares to be held in treasury. Following this latest buyback, Rec...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Continues Capital Management Drive With Treasury Share Buyback
Neutral
Jan 19, 2026
Reckitt Benckiser Group plc has repurchased 48,790 of its ordinary shares from BNP Paribas SA under its existing shareholder authority, with the shares to be held in treasury. Following this transaction, Reckitt now holds 30,195,210 shares in trea...
Stock BuybackRegulatory Filings and Compliance
Reckitt Updates Voting Rights After Latest Treasury Share Buyback
Neutral
Jan 16, 2026
Reckitt Benckiser Group plc has executed a share buyback transaction, repurchasing 48,590 ordinary shares from BNP Paribas SA under the authority granted at its May 2025 AGM, with the shares to be held in treasury. Following this transaction, Reck...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 48,660 Shares, Updates Voting Rights Count
Neutral
Jan 15, 2026
Reckitt Benckiser Group has repurchased 48,660 of its ordinary shares from BNP Paribas, under an existing shareholder-authorised buyback programme, at a volume-weighted average price of 6,162.77 pence per share, with the shares to be held in treas...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Adjusts Capital Structure With Share Buyback and Treasury Share Cancellation
Neutral
Jan 13, 2026
Reckitt Benckiser has repurchased 48,420 of its ordinary shares from BNP Paribas under a previously announced buyback instruction, with the shares to be held in treasury, while also cancelling 14 treasury shares. Following these transactions, the ...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Buys Back Shares and Adjusts Treasury Stock, Setting New Voting Rights Total
Neutral
Jan 13, 2026
Reckitt Benckiser Group has repurchased 48,420 of its ordinary shares from BNP Paribas under an existing shareholder authority, with the shares to be held in treasury, as part of its ongoing capital management activities. The company also cancelle...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Adds to Treasury Stock with New Share Buyback
Positive
Jan 12, 2026
Reckitt Benckiser Group has repurchased 48,415 of its ordinary shares from BNP Paribas SA under its existing shareholder authority, paying a volume-weighted average price of 6,196.07 pence per share. The shares will be held in treasury, bringing i...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,000 Shares, Sets New Voting Rights Total
Positive
Jan 9, 2026
Reckitt Benckiser Group plc has repurchased 49,000 of its ordinary shares from BNP Paribas SA on 8 January 2026 under an existing shareholder-authorised buyback programme, paying a volume-weighted average price of 6,112.19 pence per share and hold...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,570 Shares, Updates Voting Rights Total
Neutral
Jan 8, 2026
Reckitt Benckiser Group has repurchased 49,570 ordinary shares on 7 January 2026 from BNP Paribas as part of its ongoing share buyback programme authorised by shareholders in May 2025, with the shares to be held in treasury. Following this transac...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Continues Capital Management Drive With Latest Share Buyback
Positive
Jan 7, 2026
Reckitt Benckiser Group plc has repurchased 57,750 of its ordinary shares from BNP Paribas SA under the shareholder authority granted at its May 2025 AGM, with the repurchased stock to be held in treasury rather than cancelled. Following this tran...
Business Operations and StrategyStock BuybackDividendsM&A TransactionsShareholder MeetingsStock Split
Reckitt Sets £1.6bn Special Dividend and Share Consolidation After Essential Home Sale
Positive
Jan 7, 2026
Reckitt Benckiser Group has published a shareholder circular detailing plans to return approximately £1.6 billion of excess capital via a special dividend of 235 pence per existing ordinary share, following the completion of the divestment of...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 58,840 Shares, Updates Total Voting Rights
Neutral
Jan 6, 2026
Reckitt Benckiser Group plc has repurchased 58,840 of its ordinary shares from BNP Paribas SA under its shareholder-approved buyback authority, with the shares to be held in treasury. Following this transaction, Reckitt now holds 29,767,970 shares...
Regulatory Filings and Compliance
Reckitt Confirms Total Voting Rights at 672.4 Million Shares
Neutral
Jan 2, 2026
Reckitt Benckiser Group has confirmed that, as of 31 December 2025, it has 702,089,339 issued ordinary shares of 10p each, of which 29,709,130 are held in treasury, resulting in 672,380,209 total voting rights. This updated voting rights figure se...
Business Operations and StrategyStock BuybackDividendsM&A Transactions
Reckitt Finalises Essential Home Sale and Plans US$2.2bn Payout to Shareholders
Positive
Dec 31, 2025
Reckitt has completed the sale of its Essential Home business to private equity firm Advent International, while retaining a 30% equity stake in the acquisition vehicle, marking a significant step in its strategy to streamline operations around hi...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 46,610 Shares, Updates Voting Rights Total
Neutral
Dec 22, 2025
Reckitt Benckiser Group plc has repurchased 46,610 of its ordinary shares from BNP Paribas SA under the share buyback authority granted at its May 2025 AGM, with the shares to be held in treasury. Following this latest transaction, Reckitt now hol...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 58,330 Shares, Updates Voting Rights to 672.4 Million
Neutral
Dec 19, 2025
Reckitt Benckiser Group plc has repurchased 58,330 of its own ordinary shares from BNP Paribas SA under the shareholder authority granted at its May 2025 AGM, with the shares to be held in treasury. Following this transaction, Reckitt now holds 29...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Share Repurchase Announcement
Neutral
Dec 18, 2025
Reckitt Benckiser Group PLC announced the repurchase of 58,260 of its ordinary shares, which will be held in treasury. This move, conducted under previously granted shareholder authority, contributes to the company’s capital optimization str...
Business Operations and StrategyStock Buyback
Reckitt Benckiser Executes Share Buyback Strategy
Neutral
Dec 17, 2025
Reckitt Benckiser Group PLC announced the repurchase of 58,400 of its ordinary shares from BNP Paribas SA, as authorized by shareholders at the Annual General Meeting. The shares, bought at an average price of 5,993.10 pence, will be held in treas...
Business Operations and StrategyStock Buyback
Reckitt Benckiser Announces Share Repurchase and Cancellation
Neutral
Dec 16, 2025
Reckitt Benckiser Group PLC has repurchased 58,420 of its ordinary shares from BNP Paribas SA, with the shares to be held in treasury. Additionally, the company has canceled 30 million shares held in treasury, reducing the total number of voting r...
Stock Buyback
Reckitt Benckiser Executes Share Buyback Program
Neutral
Dec 15, 2025
Reckitt Benckiser Group PLC announced the repurchase of 49,820 of its ordinary shares from BNP Paribas SA, as part of a previously authorized share buyback program. This transaction, which will see the shares held in treasury, affects the total nu...
Stock Buyback
Reckitt Benckiser Announces Share Repurchase
Neutral
Dec 12, 2025
Reckitt Benckiser Group PLC announced the repurchase of 58,240 of its ordinary shares from BNP Paribas SA, following the authority granted by shareholders at the Annual General Meeting in May 2025. This transaction, executed under the company̵...
Stock Buyback
Reckitt Benckiser Executes Share Buyback
Neutral
Dec 11, 2025
Reckitt Benckiser Group PLC announced the repurchase of 58,800 ordinary shares from BNP Paribas SA, as authorized by shareholders, to be held in treasury. This transaction affects the company’s share structure, resulting in 672,680,502 ordin...
Business Operations and StrategyStock Buyback
Reckitt Benckiser Executes Share Buyback to Optimize Capital Structure
Positive
Dec 10, 2025
Reckitt Benckiser Group PLC announced the repurchase of 58,740 of its ordinary shares from BNP Paribas SA, as authorized by shareholders at the company’s Annual General Meeting. The shares, purchased at an average price of 5,958.11 pence, wi...
Stock Buyback
Reckitt Benckiser Executes Share Buyback Program
Neutral
Dec 9, 2025
Reckitt Benckiser Group PLC announced the repurchase of 58,900 of its ordinary shares from BNP Paribas SA, as part of a shareholder-approved buyback program. The shares, purchased at a volume-weighted average price of 5,943.08 pence, will be held ...
Stock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Executes Share Buyback, Adjusts Voting Rights
Neutral
Dec 8, 2025
Reckitt Benckiser Group PLC announced the repurchase of 56,750 of its ordinary shares, which will be held in treasury. This transaction, conducted in accordance with shareholder authority, affects the company’s total voting rights, now stand...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.